FDA Inspection
Dendreon Pharmaceuticals LLCDendreon Pharmaceuticals LLC – FDA Inspection, Oct 22, 2018
Record Details
This FDA Inspection record concerns Dendreon Pharmaceuticals LLC, with an inspection on October 22, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · e8e5b54b-3f67-4a9a-85a5-849f625ada54
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1070321
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.100(c)Record review prior to release
- 21 CFR 123.7(d)Corrective action documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dendreon Pharmaceuticals LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 29, 2025 | VAI | Atlanta District Office | Human Cellular, Tissue, and Gene Therapies |
| April 21, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 1, 2016 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Dendreon Pharmaceuticals LLC
- FDA Inspection 1286816 - 2025-10-29
- FDA Inspection 1169722 - 2022-04-21
- FDA Inspection 1031496 - 2016-11-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.